Slingshot members are tracking this event:
Portola (PTLA) Expects Committee for Medicinal Products for Human Use (CHMP) Opinion in Q4 for Betrixaban in Prevention of VTE in Acute Medically Ill Patients
Slingshot Insights Explained
Jun 23, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Chmp, Opinion, Betrixaban, Prevention Of Vte, Acute Medically Ill Patients